Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show the latest 50

REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,920 sh · $1.1M
Filed 8 Oct 2026SEC Form 4view source
ACQUIREDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−2,300 sh · $248.2K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−6,000 sh · $656.0K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−11,900 sh · $1.3M
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−900 sh · $101.5K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−100 sh · $11.0K
Filed 2 Oct 2026SEC Form 4view source
ACQUIREDT+30
Daly James M
Halozyme Therapeutics Inc · NASDAQ
+1,169 sh
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−730 sh · $78.2K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−3,300 sh · $357.9K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−1,100 sh · $120.5K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−3,000 sh · $320.5K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−3,100 sh · $329.0K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−4,000 sh · $436.0K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Posard Matthew L.
Halozyme Therapeutics Inc · NASDAQ
−8,896 sh · $961.1K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−5,412 sh · $582.2K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−15,492 sh · $1.7M
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−100 sh · $10.9K
Filed 11 Sept 2026SEC Form 4view source
ACQUIREDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−4,508 sh · $484.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−14,588 sh · $1.6M
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−13,304 sh · $1.4M
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−6,596 sh · $711.2K
Filed 11 Sept 2026SEC Form 4view source
ACQUIREDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 11 Sept 2026SEC Form 4view source
ACQUIREDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 11 Sept 2026SEC Form 4view source
ACQUIREDStale
Appelhans Dannielle
Halozyme Therapeutics Inc · NASDAQ
+1,161 sh
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,400 sh · $985.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−3,200 sh · $344.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−5,703 sh · $587.9K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−900 sh · $89.1K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,000 sh · $923.0K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−7,200 sh · $765.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,600 sh · $1.0M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−4,897 sh · $509.8K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−7,500 sh · $776.1K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−2,100 sh · $213.7K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−500 sh · $50.2K
Filed 19 Aug 2026SEC Form 4view source